selected publications
-
academic article
-
Drug response prediction in high-risk multiple myeloma.
Gene.
644.
2018
Early relapsed disease of multiple myeloma following up-front HDM-ASCT: a study based on the Danish Multiple Myeloma Registry in the period 2005 to 2014.
Leukemia.
32.
2018
Causes of early death in multiple myeloma patients treated with high‐dose therapy followed by autologous stem cell transplantation: A study based on the nationwide Danish Multiple Myeloma Registry.
American Journal of Hematology.
92.
2017
Drug Response Prediction in High Risk Multiple Myeloma.
Clinical Lymphoma Myeloma & Leukemia.
17.
2017
Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population.
PLoS ONE.
12.
2017
-
dataset
-
Baseline characteristics for the entire cohort..
public-library-of-science.
2017
Immunoparesis and association to OS and PFS in different age groups..
public-library-of-science.
2017
Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population.
public-library-of-science.
2017
Multivariable analysis of both qualitative and quantitative immunoparesis as risk factors for OS and PFS in all patients..
public-library-of-science.
2017
Multivariable analysis of factors for OS..
public-library-of-science.
2017
Multivariable analysis of factors for PFS..
public-library-of-science.
2017